Literature DB >> 27196127

Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors.

Kah-Lok Chan1, Piers Blombery1, Kate Jones1, Stephen Lade2, Dennis Carney1, Huy Tran3, John F Seymour1,4, Constantine S Tam1,4.   

Abstract

Entities:  

Keywords:  B-cell receptor signalling inhibitors; Chronic lymphocytic leukaemia; ibrutinib; plasmablastic lymphoma; richter transformation

Mesh：

Year:  2016        PMID： 27196127     DOI： 10.1111/bjh.14062

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Targeted Therapy in Chronic Lymphocytic Leukemia.

Authors:  Thomas J Kipps; Michael Y Choi
Journal:  Cancer J       Date:  2019 Nov/Dec       Impact factor: 3.360

2.  PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment.

Authors:  D Jones; J A Woyach; W Zhao; S Caruthers; H Tu; J Coleman; J C Byrd; A J Johnson; G Lozanski
Journal:  Leukemia       Date:  2017-04-03       Impact factor: 11.528

3.  Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.

Authors:  Ferran Nadeu; Romina Royo; Ramon Massoni-Badosa; Heribert Playa-Albinyana; Beatriz Garcia-Torre; Martí Duran-Ferrer; Kevin J Dawson; Marta Kulis; Ander Diaz-Navarro; Neus Villamor; Juan L Melero; Vicente Chapaprieta; Ana Dueso-Barroso; Julio Delgado; Riccardo Moia; Sara Ruiz-Gil; Domenica Marchese; Ariadna Giró; Núria Verdaguer-Dot; Mónica Romo; Guillem Clot; Maria Rozman; Gerard Frigola; Alfredo Rivas-Delgado; Tycho Baumann; Miguel Alcoceba; Marcos González; Fina Climent; Pau Abrisqueta; Josep Castellví; Francesc Bosch; Marta Aymerich; Anna Enjuanes; Sílvia Ruiz-Gaspà; Armando López-Guillermo; Pedro Jares; Sílvia Beà; Salvador Capella-Gutierrez; Josep Ll Gelpí; Núria López-Bigas; David Torrents; Peter J Campbell; Ivo Gut; Davide Rossi; Gianluca Gaidano; Xose S Puente; Pablo M Garcia-Roves; Dolors Colomer; Holger Heyn; Francesco Maura; José I Martín-Subero; Elías Campo
Journal:  Nat Med       Date:  2022-08-11       Impact factor: 87.241

4.  Plasmablastic Lymphoma with Coexistence of Chronic Lymphocytic Leukemia in an Immunocompetent Patient: A Case Report and Mini-Review.

Authors:  Eleftheria Hatzimichael; Konstantina Papathanasiou; Ioannis Zerdes; Stefanos Flindris; Alexandra Papoudou-Bai; Eleni Kapsali
Journal:  Case Rep Hematol       Date:  2017-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.